{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"萌喵读文献-肿瘤学","title":"今日肿瘤学最高分文献 - 2025-05-25","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/663d5790\"></iframe>","width":"100%","height":180,"duration":4,"description":"欢迎收听科研喵播客，使用AI读文献，祝你效率百倍，快来labcat.com.cn下载吧。最新的医学研究揭示了腹腔内化疗对抗腹膜转移瘤的潜力。面对卵巢、结肠、胰腺和胃癌等癌症的腹膜转移，传统化疗效果有限。而腹腔内化疗能提供高浓度药物，增强疗效，减少全身毒性。研究探讨了三种腹腔内化疗方法：热腹腔化疗(HIPEC)、加压腹腔气溶胶化疗(PIPAC)和基于导管的腹腔化疗(CBIP)，它们在药物动力学方面各有优势。研究还评估了常用药物，如铂类药物、紫杉醇和新型纳米颗粒制剂的药动学数据。虽然药动学原理支持腹腔内化疗，但仍需等待临床试验结果。纳米颗粒和控释系统的创新有望提高药物保留和靶向输送，减少全身毒性。持续探索这些领域，优化化疗方案，对提高患者疗效、优化治疗策略至关重要。","thumbnail_url":"https://img.transistorcdn.com/3WX36CzvFOrNjlF7WfWjzS4HdcMIMmzMs2bmPS-ejLU/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS83NDNm/MjQ1N2E5NjhjMzVj/NjM0ZTA3YzY2NDE2/ZmIyMi5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}